JB

JJP Biologics at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

JJP Biologics takes part in 3 sessions at Festival of Biologics 2026 in Basel. Its program centres on antibodies that steer the immune system, along with next-generation antibody formats. Topics include JJP1008, an antibody that activates T cells in lab models of melanoma, and nebaprubart, a first-of-its-kind antibody that blocks CD89.

OrganizationFestival of Biologics 2026 Attendance
JB
JJP Biologics
Warsaw, Poland
Talk
Tue Oct 13
14:10
Targeting T Cell Activation with JJP1008: A Novel Agonistic mAb in Preclinical Melanoma Cancer Models
mAbs
Panel
Tue Oct 13
17:30
Panel Discussion: Next Generation Antibody Formats
Where antibody drug design is heading, from two-target antibodies and antibody-drug conjugates to AI's role in engineering them.
with Novartis, UCB, FairJourney Biologics
Keynote
Thu Oct 15
09:55
nebaprubart (JJP-1212) - Advancing a first-in-class anti-CD89 antagonist
Antibody Keynotes

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from JJP Biologics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction